... the right product for any patient ranging from pe...patients with tracheotomies. These products offer ...itical care applications., ,The Unti-Mist HME and...ts and staff members. This entire product line of ...
Combination heat and moisture exchanger and bacterial/viral filters for Anesthesia and Respiratory applications.
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend
Medicine Products:(Date:12/3/2008)...STERDAM, The Netherlands, and LOS ANGELES, Dec. 3 ...ed Kari Boiler as the President of Bugaboo,Americ...boo North America for,the past 5 years. "Kari Boi...ong leader but a great team player with the vision..." says Arjan Muis, CEO of Bugaboo International. ,...
(Date:12/3/2008)...N FRANCISCO, Dec. 3 In ...ematology (ASH) places on mentorship, ASH is proud...y, M.D., with ASH Mentor Awards, which highlight t... professional development of hematologists early i...s -- one from the discipline of laboratory science...
(Date:12/3/2008)...N FRANCISCO, Dec. 3 The...s annual High School Student Symposium at the San ...beginning at 8:00 a.m. PST. The symposium, which e...l sciences, and medical research, is held in conju...s year, students will have the opportunity to expl...
(Date:12/3/2008)...N FRANCISCO, Dec. 3 The... largest professional association of blood special...th ASH Annual Meeting from December 6-9, 2008, at ...ng will showcase the latest research and treatment...olden anniversary, there will also be several spec...
Breaking Medicine News(10 mins):Health News:Kari Boiler Named President of Bugaboo Americas 2Health News:Inspirational Hematologists Honored With Mentor Awards From the American Society of Hematology 2Health News:ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 2Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 3Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 4...t get training posts through the flawed Medical Tr...er misery because the government// is stalling on ... BMA warns. Latest figures show that 34,250 docto...ing posts in the UK. The government has so far giv...
... (CFS) has been associated with altered amounts of...troencephalograph// (EEG) activity and impaired sl...the journal SLEEP finds that CFS is also associate... sleep challenge, suggesting an impairment of the ...
...origin optician who was part of a British charity,... volunteering// in India. Premal Patel, who was p...harity, carried out a record 850 eye examinations ... of Bangalore in March. The charity helps people ...
...ls are setting new trends in drug abuse- drugs suc...isused//, a report has shown. Teen boys have been...g a slice of the vice, teen girls have become a ca...cription drugs, according to the White House Offic...
Other Medicine News:Health News:Junior Doctors Facing More Misery Because of Contract Deadlock: BMA 2(Date:12/3/2008)...tCall/ -- Sangamo BioSciences, Inc.,(Nasdaq: SG...date on milestones,achieved in 2008 and preview o... Analyst Briefing to be held in New York City toda...ldrich Corporation,s Research,Biotech Business Un...l of the,two companies, collaboration to commerci...
(Date:12/3/2008)... long-term anemia and organ damage in mice and pav...HIS, Tenn., Dec. 3 Usin...o mouse blood cells, scientists at St. Jude Childr... disease pathology. In their studies, the research... no difference from normal mice. Although the scie...
(Date:12/3/2008)...swire/ -- The Leukemia & Lymphoma Society (LLS...f a new clinical trial of ISF35, a cancer vaccine,...D). , , LLS is collaborating on this tria...and approval of a novel approach aimed at treating...eleted chronic lymphocytic leukemia (CLL). , ...
(Date:12/3/2008)...wire-FirstCall/ -- Wyeth Pharmaceuticals,a divis...it has submitted a,marketing authorization applic...A) for approval to market its investigational 13-v...infants and young children. Wyeth is seeking an,...ase (PD) caused by the 13,serotypes included in t...
Breaking Medicine Technology:Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5QUITPLAN 28R 29 Services Can Help Make Fathers Day Smoke Free 21571 1QUITPLAN 28R 29 Services Can Help Make Fathers Day Smoke Free 21571 2Oncothyreon initiates Phase 1b trial of PX 12 in patients with advanced metastatic cancer 5933 1Oncothyreon initiates Phase 1b trial of PX 12 in patients with advanced metastatic cancer 5933 2Oncothyreon initiates Phase 1b trial of PX 12 in patients with advanced metastatic cancer 5933 3Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 5928 1Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 5928 2Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 5928 3HeartCentrix Informatics Solution from Cardiac Science Now Certified with Allscripts Electronic Health Records 21564 1HeartCentrix Informatics Solution from Cardiac Science Now Certified with Allscripts Electronic Health Records 21564 2HeartCentrix Informatics Solution from Cardiac Science Now Certified with Allscripts Electronic Health Records 21564 3...NG, Pa., June 19, 2007 /PRNewswire-FirstCall/ --,G...esent a poster,on trodusquemine (MSI-1436), its no...betes Association (ADA) 67th Scientific,Sessions, ..., is titled, "Trodusquemine is a Multiple,Pathway ...duces,Adiposity, and Improves Plasma Insulin and L...
... abstracts highlight VELCADE efficacy in broad ran...MBRIDGE, Mass., June 19, 2007 /PRNewswire-FirstCal...nced that data for,VELCADE, the market leading the...tients with previously treated multiple myeloma,(M... Myeloma,Workshop (IMW) in Kos, Greece, June 25-30...
Other Medicine Technology:Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8